Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,826 | 1,411 | 2,112 | 1,393 | 813 |
| Gross Profit | 1,826 | 1,411 | 2,112 | 1,393 | 813 |
| Operating Expenses | 20,241 | 22,451 | 24,458 | 24,452 | 24,689 |
| Operating Income | -18,415 | -21,040 | -22,346 | -23,059 | -23,876 |
| Other Income | 1,435 | 1,043 | 587 | 395 | 198 |
| Pre-tax Income | -16,980 | -19,997 | -21,759 | -22,664 | -23,678 |
| Net Income Continuous | -16,980 | -19,997 | -21,759 | -22,664 | -23,678 |
| Net Income | $-16,980 | $-19,997 | $-21,759 | $-22,664 | $-23,678 |
| EPS Basic Total Ops | -9.00 | -10.60 | -11.60 | -12.20 | -12.80 |
| EPS Basic Continuous Ops | -9.01 | -10.64 | -11.62 | -12.15 | -12.75 |
| EPS Diluted Total Ops | -9.00 | -10.60 | -11.60 | -12.20 | -12.80 |
| EPS Diluted Continuous Ops | -9.01 | -10.64 | -11.62 | -12.15 | -12.75 |
| EBITDA(a) | $-18,800 | $-21,049 | $-21,945 | $-22,424 | $-23,053 |